Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael W Fried

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Plos One|September 20, 2019
Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trialVictor J Navarro, Steven H Belle, Massimo D'Amato, et al.
Gastroenterology|January 30, 2007
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis CYing Huang, Jordan J Feld, Ronda K Sapp, et al.
Digestive Diseases and Sciences|June 1, 2021
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBVDavid E Bernstein, Huy N Trinh, Eugene R Schiff, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 11, 2002
Metastatic leiomyosarcoma mimicking polycystic liver diseaseKimberly L Beavers, Michael W Fried, Mark W Johnson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2002
Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: a matched, case-controlled studyElizabeth W Jackson, Steven Zacks, Sandra Zinn, et al.
Clinical Trials (London, England)|November 8, 2011
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis CK Rajender Reddy, Steven H Belle, Michael W Fried, et al.
JAMA|July 17, 2012
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialMichael W Fried, Victor J Navarro, Nezam Afdhal, et al.
Journal of Virology|May 25, 2012
Unexpected maintenance of hepatitis C viral diversity following liver transplantationRebecca R Gray, Samantha L Strickland, Nazle M Veras, et al.
Hepatology Communications|April 6, 2018
Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohortPaul Kwo, Michael W Fried, K Rajender Reddy, et al.
Journal of Hepatology|June 25, 2017
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysisFred Poordad, David R Nelson, Jordan J Feld, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Plos One|September 20, 2019
Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trialVictor J Navarro, Steven H Belle, Massimo D'Amato, et al.
Gastroenterology|January 30, 2007
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis CYing Huang, Jordan J Feld, Ronda K Sapp, et al.
Digestive Diseases and Sciences|June 1, 2021
Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBVDavid E Bernstein, Huy N Trinh, Eugene R Schiff, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 11, 2002
Metastatic leiomyosarcoma mimicking polycystic liver diseaseKimberly L Beavers, Michael W Fried, Mark W Johnson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2002
Delayed neuropsychologic dysfunction after liver transplantation for acute liver failure: a matched, case-controlled studyElizabeth W Jackson, Steven Zacks, Sandra Zinn, et al.
Clinical Trials (London, England)|November 8, 2011
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis CK Rajender Reddy, Steven H Belle, Michael W Fried, et al.
JAMA|July 17, 2012
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialMichael W Fried, Victor J Navarro, Nezam Afdhal, et al.
Journal of Virology|May 25, 2012
Unexpected maintenance of hepatitis C viral diversity following liver transplantationRebecca R Gray, Samantha L Strickland, Nazle M Veras, et al.
Hepatology Communications|April 6, 2018
Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohortPaul Kwo, Michael W Fried, K Rajender Reddy, et al.
Journal of Hepatology|June 25, 2017
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysisFred Poordad, David R Nelson, Jordan J Feld, et al.
Pageof 17